Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sundan

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
Cytokine|September 10, 1999
Regulation of APO-2 ligand/trail expression in NK cells-involvement in NK cell-mediated cytotoxicityA C Johnsen, J Haux, B Steinkjer, et al.
European Journal of Haematology|August 12, 2008
Elevated serum concentrations of activated hepatocyte growth factor activator in patients with multiple myelomaK F Wader, U M Fagerli, R U Holt, et al.
Journal of Leukocyte Biology|March 23, 2001
Differential expression of Toll-like receptor 2 in human cellsT H Flo, O Halaas, S Torp, et al.
Leukemia|April 18, 2006
Toll-like receptors mediate proliferation and survival of multiple myeloma cellsJ Bohnhorst, T Rasmussen, S H Moen, et al.
Blood|January 11, 2000
Serum syndecan-1: a new independent prognostic marker in multiple myelomaC Seidel, A Sundan, M Hjorth, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 5, 2000
Human toll-like receptor 2 mediates monocyte activation by Listeria monocytogenes, but not by group B streptococci or lipopolysaccharideT H Flo, O Halaas, E Lien, et al.
British Journal of Haematology|June 3, 1999
Hepatocyte growth factor in serum after injection of unfractionated and low molecular weight heparin in healthy individualsC Seidel, H Hjorth-Hansen, B Bendz, et al.
Cytokine|June 1, 1997
Regulation of Fas and Fas-ligand expression in NK cells by cytokines and the involvement of Fas-ligand in NK/LAK cell-mediated cytotoxicityA E Medvedev, A C Johnsen, J Haux, et al.
British Journal of Haematology|August 6, 2000
Expression of urokinase plasminogen activator and the urokinase plasminogen activator receptor in myeloma cellsO Hjertner, G Qvigstad, H Hjorth-Hansen, et al.
British Journal of Urology|December 11, 1997
Soluble urinary CD14 after intravesical bacille Calmette-Guérin immunotherapy for carcinoma in situA M Jackson, E Lien, A B Alexandroff, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Cytokine|September 10, 1999
Regulation of APO-2 ligand/trail expression in NK cells-involvement in NK cell-mediated cytotoxicityA C Johnsen, J Haux, B Steinkjer, et al.
European Journal of Haematology|August 12, 2008
Elevated serum concentrations of activated hepatocyte growth factor activator in patients with multiple myelomaK F Wader, U M Fagerli, R U Holt, et al.
Journal of Leukocyte Biology|March 23, 2001
Differential expression of Toll-like receptor 2 in human cellsT H Flo, O Halaas, S Torp, et al.
Leukemia|April 18, 2006
Toll-like receptors mediate proliferation and survival of multiple myeloma cellsJ Bohnhorst, T Rasmussen, S H Moen, et al.
Blood|January 11, 2000
Serum syndecan-1: a new independent prognostic marker in multiple myelomaC Seidel, A Sundan, M Hjorth, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 5, 2000
Human toll-like receptor 2 mediates monocyte activation by Listeria monocytogenes, but not by group B streptococci or lipopolysaccharideT H Flo, O Halaas, E Lien, et al.
British Journal of Haematology|June 3, 1999
Hepatocyte growth factor in serum after injection of unfractionated and low molecular weight heparin in healthy individualsC Seidel, H Hjorth-Hansen, B Bendz, et al.
Cytokine|June 1, 1997
Regulation of Fas and Fas-ligand expression in NK cells by cytokines and the involvement of Fas-ligand in NK/LAK cell-mediated cytotoxicityA E Medvedev, A C Johnsen, J Haux, et al.
British Journal of Haematology|August 6, 2000
Expression of urokinase plasminogen activator and the urokinase plasminogen activator receptor in myeloma cellsO Hjertner, G Qvigstad, H Hjorth-Hansen, et al.
British Journal of Urology|December 11, 1997
Soluble urinary CD14 after intravesical bacille Calmette-Guérin immunotherapy for carcinoma in situA M Jackson, E Lien, A B Alexandroff, et al.
Pageof 8